Skip to content
10-Q

Quarterly Report

ANDES 7 INC.

0001262463-19-000205

← back to feed
Filed
Jun 18, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · Jun 17, 2019 120.1M sh
Capex Q1 2019 · Mar 31, 2019 $4.77K
Capex Q1 2019 · Mar 31, 2018 $8.53K
Cash And Equivalents Q1 2019 · Mar 31, 2019 $1.54K
Cash And Equivalents Q1 2019 · Dec 31, 2018 $2.22K
Cash And Equivalents Q1 2019 · Mar 31, 2018 $3.18K
Cash And Equivalents Q1 2019 · Dec 31, 2017 $59.94K
Current Liabilities Q1 2019 · Mar 31, 2019 $1.35M
Current Liabilities Q1 2019 · Dec 31, 2018 $1.3M
Total Liabilities Q1 2019 · Mar 31, 2019 $1.37M
Total Liabilities Q1 2019 · Dec 31, 2018 $1.31M
Current Assets Q1 2019 · Mar 31, 2019 $87.73K
Current Assets Q1 2019 · Dec 31, 2018 $87.44K
Total Assets Q1 2019 · Mar 31, 2019 $636.25K
Total Assets Q1 2019 · Dec 31, 2018 $632.55K
Operating Cash Flow restated Q1 2019 · Mar 31, 2018 −$207.3K
Stockholders Equity restated Q1 2019 · Mar 31, 2018 −$544.32K
Stockholders Equity restated Q1 2019 · Dec 31, 2017 −$434.82K
Sga Expense restated Q1 2019 · Mar 31, 2018 $92.79K
Net Income restated Q1 2019 · Mar 31, 2018 −$108.58K
Operating Income restated Q1 2019 · Mar 31, 2018 −$107.22K
Gross Profit Q1 2019 · Mar 31, 2018 −$2.04K
Cost Of Revenue Q1 2019 · Mar 31, 2018 $2.89K
Revenue Q1 2019 · Mar 31, 2018 $856